Clinical Trial Update: SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of SON-DP in participants with relapsed/refractory solid tumors intolerant to standard therapies, including gastric cancer and hepatocellular carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• SON-DP (SON-DP)

Snippet

Sponsor: Qurgen Inc. | Conditions: Solid Tumor, Gastric Cancer | Phase 1 | Status: RECRUITING